Catabasis   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2008)

Organization Overview

First Clinical Trial
2011
NCT01440166
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Catabasis Pharmaceuticals | Chief Medical Officer, Catabasis